| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $12.8M | +2.6% |
| SG&A Expense | $4.3M | -4.1% |
| Operating Income | -$17.1M | -0.8% |
| Interest Expense | $210K | -89.8% |
| Net Income | -$17.2M | +7.5% |
| EPS (Basic) | -$0.15 | +16.7% |
| EPS (Diluted) | -$0.15 | +16.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.1M | +2.9% |
| Current Assets | $25.4M | +7.1% |
| Total Assets | $29.3M | +7.5% |
| Current Liabilities | $1.5M | -5.2% |
| Total Liabilities | $1.7M | -15.5% |
| Stockholders' Equity | $27.6M | +9.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.5M | -4.3% |
| Capital Expenditures | $1.3M | +19.1% |
| Investing Cash Flow | -$2.2M | -98.0% |
| Financing Cash Flow | $13.3M | -57.3% |
| Free Cash Flow | -$11.8M | -5.7% |